FWBTX
Price
$15.69
Change
-$0.02 (-0.13%)
Updated
Oct 17 closing price
Net Assets
3.15B
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

FWBTX vs RLBCX

Header iconFWBTX vs RLBCX Comparison
Open Charts FWBTX vs RLBCXBanner chart's image
Fidelity Advisor Multi-Asset Income C
Price$15.69
Change-$0.02 (-0.13%)
VolumeN/A
Net Assets3.15B
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
FWBTX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
FWBTX vs. RLBCX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FWBTX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. FWBTX (3.15B). FWBTX pays higher dividends than RLBCX: FWBTX (2.82) vs RLBCX (1.49). FWBTX was incepted earlier than RLBCX: FWBTX (10 years) vs RLBCX (23 years). FWBTX (1.84) is less costly to investors than RLBCX (0.89). FWBTX is a more actively managed with annual turnover of: 230.00 vs. RLBCX (44.00). FWBTX has a lower initial minimum investment than RLBCX: FWBTX (0) vs RLBCX (250). FWBTX annual gain was more profitable for investors over the last year : 12.87 vs. RLBCX (8.34). FWBTX return over 5 years is better than : 46.79 vs. RLBCX (40.24).
FWBTXRLBCXFWBTX / RLBCX
Total Expense Ratio1.840.89207%
Annual Report Gross Expense Ratio1.840.89207%
Fund Existence10 years23 years-
Gain YTD14.08914.36498%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.15B265B1%
Annual Yield % from dividends2.821.49190%
Returns for 1 year12.878.34154%
Returns for 3 years40.8649.2683%
Returns for 5 years46.7940.24116%
Returns for 10 years100.0272.18139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN24.211.20
+5.22%
Viridian Therapeutics
ACI19.740.51
+2.65%
Albertsons Companies
PRFX1.24N/A
-0.40%
PainReform Ltd
BOC13.76-0.10
-0.72%
Boston Omaha Corp
ASRT0.80-0.02
-2.90%
Assertio Holdings